Related Experiment Videos
DR antigen distribution in Blacks with rheumatoid arthritis
The Journal of Rheumatology
|August 1, 1983
Summary
The human leukocyte antigen DR4 (DR4) is associated with rheumatoid arthritis (RA) in Black individuals. This finding suggests DR4 may increase the risk of more severe rheumatoid arthritis (RA) in this population.
Area of Science:
- Immunogenetics
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Genetic factors, including human leukocyte antigen (HLA) genes, play a role in RA susceptibility and severity.
- Previous studies have shown an association between HLA-DR4 and RA in various ethnic groups.
Purpose of the Study:
- To investigate the distribution of the DR antigen in Black patients with rheumatoid arthritis (RA).
- To determine if the DR4 antigen is associated with seropositive and seronegative RA in Black individuals.
- To explore the potential role of DR4 as a risk factor for aggressive RA in Black populations.
Main Methods:
- A case-control study was conducted involving 85 Black patients diagnosed with rheumatoid arthritis (RA).
- Patients were categorized into seropositive (n=63) and seronegative (n=22) groups based on latex fixation titer.
- DR antigen frequencies were compared between RA patients and a control Black population (n=162).
Main Results:
- The frequency of DR4 was significantly higher in both seropositive (22.22%) and seronegative (22.72%) RA patients compared to the Black control population (7.41%).
- A strong association was observed between DR4 and seropositive RA (Relative Risk [RR] = 3.57).
- A similar significant association was found between DR4 and seronegative RA (RR = 3.67).
Conclusions:
- The study confirms the association of DR4 with seropositive rheumatoid arthritis (RA) in Black individuals.
- The findings suggest a comparable association between DR4 and seronegative RA in this population.
- DR4 may represent a genetic risk factor for more aggressive rheumatoid arthritis (RA) in Black patients.